The active ingredient of Synspira’s SNSP113, an inhaled…
Ana Pena, PhD
Ana is a molecular biologist enthusiastic about innovation and communication. In her role as a science writer she wishes to bring the advances in medical science and technology closer to the public, particularly to those most in need of them. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she focused her research on molecular biology, epigenetics and infectious diseases.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana Pena, PhD
Disease severity in cystic fibrosis (CF) may be associated with an overreaction of the immune system to…
A new population of lung stem cells capable of repairing the airways following a severe injury was identified…
Celtaxsys has obtained four U.S. patents, including a new one for acebilustat, its lead candidate for treating the lung inflammation…
A single dose of inhaled hypertonic saline (HS)Â solution increases mucus clearance for at least four hours in adults with…